Product Approval Information - Licensing Action
Proper name: Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed (DTaP)
Tradename: DAPTACEL
Manufacturer: Aventis Pasteur Limited, Toronto, Ontario, License #1280
Indication for Use: Active immunization of infants and toddlers at 2, 4, 6, and 17-20 months of age against diphtheria, tetanus and pertussis
Approval Date: 5/14/2002
Type of submission: Biologics license application
Approval Letter -
(PDF),
(Text)
Label - (PDF)
Clinical Review - (PDF)
|